Effects of 3,4-Methylenedioxymethamphetamine on Conditioned Fear Extinction and Retention in a Crossover Study in Healthy Subjects

Background: 3,4-Methylenedioxymethamphetamine (MDMA) has shown initial promise as an adjunct in psychotherapy to treat posttraumatic stress disorder (PTSD). Its efficacy and safety have been demonstrated across phase I–III studies. However, the mechanism underlying the potential utility of MDMA to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vizeli, Patrick, Straumann, Isabelle, Duthaler, Urs, Varghese, Nimmy, Eckert, Anne, Paulus, Martin P., Risbrough, Victoria, Liechti, Matthias E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326355/
https://www.ncbi.nlm.nih.gov/pubmed/35910354
http://dx.doi.org/10.3389/fphar.2022.906639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326355/
https://www.ncbi.nlm.nih.gov/pubmed/35910354
http://dx.doi.org/10.3389/fphar.2022.906639

Ejemplares similares